Improving health outcomes through SDOH

NOVA ScriptsCentral is excited to collaborate with the American Pharmacist Association to launch the “NOVA ScriptsCentral & American Pharmacist Association Safety-Net Health Equity Fellowship”.

Charitable Pharmacies of America organization member receives Health Equity grant

Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.

Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections

Three Healthcare Organizations Join Forces to Save Lives

Patients taking opioid dosages at or above 50 MME/day are twice as likely to overdose compared to those taking 20 MME/day, and the risk further increases as the MME/day increases.

Patients taking opioid dosages at or above 50 MME/day are twice as likely to overdose compared to those taking 20 MME/day, and the risk further increases as the MME/day increases.

How a ‘weighted lottery’ helped underserved patients get a scarce Covid drug

Medication non-adherence has led to at least 100,000 preventable deaths each year and $100 billion annually in preventable healthcare costs in the United States

We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…

The five most recent states to expand the scope of reimbursement for pharmacists are Maryland, Missouri, North Dakota, Virginia and Wyoming

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

Charitable Pharmacies of America organization member receives Health Equity grant

APPLICATIONS ARE OPEN! – Letters of Intent due 9/15/23

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.